FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2342751707> ?p ?o ?g. }

• W2342751707 endingPage "122" @default.
• W2342751707 startingPage "115" @default.
• W2342751707 abstract "Urapidil has been proposed to be an effective vasodilator for the treatment of acute decompensated heart failure (ADHF); however, its effect on cardiac function, as compared with that of nitroglycerin, in elderly patients with hypertension and ADHF has yet to be determined. In the present study, a multicenter, open‑label clinical trial was performed, in which 120 elderly patients with hypertension and ADHF were randomly assigned to the treatment (50‑400 µg/min intravenous urapidil) or control group (5‑40 µg/min intravenous nitroglycerin). The dosages of the medications were adjusted according to the blood pressure of the patients. The systolic and diastolic blood pressure, heart rate and serum level of N‑terminal pro B‑type natriuretic peptide (NT‑proBNP) were evaluated at hospital admission and at days 1, 2, 3 and 7 after treatment. In addition, the left ventricular function was assessed by measuring the left ventricular ejection fraction (LVEF) and left ventricular end‑diastolic volume at hospital admission and at days 2 and 7 after treatment. The results indicated that intravenous administration of urapidil and nitroglycerin were effective in lowering the blood pressure and heart rate within 7 days, with no significant differences observed between the two groups (P>0.05). By contrast, greater reduction in the serum NT‑proBNP level (2,410.4±546.1 vs. 4,234.1±876.4 pg/ml; P<0.05) and greater improvement in the LVEF (55.3±3.4 vs. 45.2±2.4%; P<0.05) were observed in the urapidil‑treated group, as compared with the nitroglycerin‑treated group. No adverse events were reported during the treatment period in the two groups. The clinical outcomes at 6 months following discharge were evaluated and were not found to be significantly different between the two groups. In conclusion, the present results of the present study suggested that urapidil was as effective as nitroglycerin in controlling blood pressure and heart rate and was more effective in improving cardiac systolic function in elderly patients with hypertension and ADHF." @default.
• W2342751707 created "2016-06-24" @default.
• W2342751707 creator A5008839625 @default.
• W2342751707 creator A5013039304 @default.
• W2342751707 creator A5041882455 @default.
• W2342751707 creator A5042914048 @default.
• W2342751707 creator A5043332029 @default.
• W2342751707 creator A5046561927 @default.
• W2342751707 creator A5056839008 @default.
• W2342751707 creator A5059059454 @default.
• W2342751707 creator A5069718210 @default.
• W2342751707 creator A5070192698 @default.
• W2342751707 creator A5070707659 @default.
• W2342751707 creator A5073581902 @default.
• W2342751707 creator A5079908947 @default.
• W2342751707 creator A5088926848 @default.
• W2342751707 date "2016-04-27" @default.
• W2342751707 modified "2023-10-13" @default.
• W2342751707 title "Therapeutic effects of intravenous urapidil in elderly patients with hypertension and acute decompensated heart failure: A pilot clinical trial" @default.
• W2342751707 cites W1608429456 @default.
• W2342751707 cites W191052600 @default.
• W2342751707 cites W1969563531 @default.
• W2342751707 cites W1976197893 @default.
• W2342751707 cites W1977010103 @default.
• W2342751707 cites W1990029863 @default.
• W2342751707 cites W1993823264 @default.
• W2342751707 cites W2002439304 @default.
• W2342751707 cites W2005998019 @default.
• W2342751707 cites W2008491551 @default.
• W2342751707 cites W2015421740 @default.
• W2342751707 cites W2023940327 @default.
• W2342751707 cites W2031167728 @default.
• W2342751707 cites W2031836264 @default.
• W2342751707 cites W2039785869 @default.
• W2342751707 cites W2057562183 @default.
• W2342751707 cites W2060376963 @default.
• W2342751707 cites W2064007314 @default.
• W2342751707 cites W2076693114 @default.
• W2342751707 cites W2086322914 @default.
• W2342751707 cites W2086378904 @default.
• W2342751707 cites W2091382004 @default.
• W2342751707 cites W2108790161 @default.
• W2342751707 cites W2119340816 @default.
• W2342751707 cites W2142778898 @default.
• W2342751707 cites W2149379017 @default.
• W2342751707 cites W2159492161 @default.
• W2342751707 cites W2159716032 @default.
• W2342751707 cites W2268011077 @default.
• W2342751707 cites W2279768366 @default.
• W2342751707 cites W2409863440 @default.
• W2342751707 cites W2431666668 @default.
• W2342751707 cites W3151176453 @default.
• W2342751707 cites W4292497465 @default.
• W2342751707 cites W4293084779 @default.
• W2342751707 doi "https://doi.org/10.3892/etm.2016.3302" @default.
• W2342751707 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4906984" @default.
• W2342751707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27347026" @default.
• W2342751707 hasPublicationYear "2016" @default.
• W2342751707 type Work @default.
• W2342751707 sameAs 2342751707 @default.
• W2342751707 citedByCount "4" @default.
• W2342751707 countsByYear W23427517072018 @default.
• W2342751707 countsByYear W23427517072020 @default.
• W2342751707 countsByYear W23427517072022 @default.
• W2342751707 crossrefType "journal-article" @default.
• W2342751707 hasAuthorship W2342751707A5008839625 @default.
• W2342751707 hasAuthorship W2342751707A5013039304 @default.
• W2342751707 hasAuthorship W2342751707A5041882455 @default.
• W2342751707 hasAuthorship W2342751707A5042914048 @default.
• W2342751707 hasAuthorship W2342751707A5043332029 @default.
• W2342751707 hasAuthorship W2342751707A5046561927 @default.
• W2342751707 hasAuthorship W2342751707A5056839008 @default.
• W2342751707 hasAuthorship W2342751707A5059059454 @default.
• W2342751707 hasAuthorship W2342751707A5069718210 @default.
• W2342751707 hasAuthorship W2342751707A5070192698 @default.
• W2342751707 hasAuthorship W2342751707A5070707659 @default.
• W2342751707 hasAuthorship W2342751707A5073581902 @default.
• W2342751707 hasAuthorship W2342751707A5079908947 @default.
• W2342751707 hasAuthorship W2342751707A5088926848 @default.
• W2342751707 hasBestOaLocation W23427517071 @default.
• W2342751707 hasConcept C126322002 @default.
• W2342751707 hasConcept C164705383 @default.
• W2342751707 hasConcept C2777953023 @default.
• W2342751707 hasConcept C2778040405 @default.
• W2342751707 hasConcept C2778198053 @default.
• W2342751707 hasConcept C2779295919 @default.
• W2342751707 hasConcept C42219234 @default.
• W2342751707 hasConcept C71924100 @default.
• W2342751707 hasConcept C78085059 @default.
• W2342751707 hasConcept C84393581 @default.
• W2342751707 hasConceptScore W2342751707C126322002 @default.
• W2342751707 hasConceptScore W2342751707C164705383 @default.
• W2342751707 hasConceptScore W2342751707C2777953023 @default.
• W2342751707 hasConceptScore W2342751707C2778040405 @default.
• W2342751707 hasConceptScore W2342751707C2778198053 @default.
• W2342751707 hasConceptScore W2342751707C2779295919 @default.
• W2342751707 hasConceptScore W2342751707C42219234 @default.
• W2342751707 hasConceptScore W2342751707C71924100 @default.

• next